Drug induced pancreatitis

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 2, 2010, Pages 143-155

  Nitsche, Claudia J ^a   Jamieson, Nigel ^b   Lerch, Markus M ^a   Mayerle, Julia V ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Acute pancreatitis; Adverse drug reaction; Aetiology; Medication

Indexed keywords

ALBINTERFERON ALPHA2B; ALLOPURINOL; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CAPTOPRIL; COLESTYRAMINE; DIDANOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FLUINDOSTATIN; FUROSEMIDE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEASLES MUMPS RUBELLA VACCINE; MESALAZINE; METRONIDAZOLE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; RITONAVIR; SALAZOSULFAPYRIDINE; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; STAVUDINE; TICLOPIDINE; UNINDEXED DRUG; VALPROIC ACID; ZALCITABINE;

ARTICLE; ATTRIBUTABLE RISK; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CASE CONTROL STUDY; CHRONIC DRUG ADMINISTRATION; CROHN DISEASE; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG REEXPOSURE; ENTERITIS; EPIDEMIOLOGICAL DATA; HELICOBACTER INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LOW DRUG DOSE; NONHUMAN; PANCREATITIS; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS;

DRUG THERAPY; HUMANS; PANCREAS; PANCREATITIS; RISK ASSESSMENT; RISK FACTORS;

EID: 77749310342     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.02.002     Document Type: Article

References (27)

1. Lancashire R.J., Cheng K., and Langman M.J. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 17 7 (2003 Apr 1) 887-893
2. Balani A.R., and Grendell J.H. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf 31 10 (2008) 823-837
3. Lankisch P.G., Droge M., and Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut 37 4 (1995 Oct) 565-567
4. Andersen V., Sonne J., and Andersen M. Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol 57 6-7 (2001 Sep) 517-521
5. Eland I.A., van Puijenbroek E.P., Sturkenboom M.J., Wilson J.H., Stricker B.H., et al. Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol 94 9 (1999 Sep) 2417-2422
6. Parenti D.M., Steinberg W., and Kang P. Infectious causes of acute pancreatitis. Pancreas 13 4 (1996) 356-371
7. Sibert J.R. Pancreatitis in children. A study in the North of England. Arch Dis Child 50 6 (1975) 443-448
8. Dutta S.K., Ting C.D., and Lai L.L. Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus. Am J Gastroenterol 92 11 (1997 Nov) 2044-2048
9. Demols A., et al. CD4(+)T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology 118 3 (2000) 582-590
10. Qiao S.F., et al. Alterations of intestinal immune function and regulatory effects of L-arginine in experimental severe acute pancreatitis rats. World J Gastroenterol 11 39 (2005) 6216-6218
11. Munk E.M., Pedersen L., Floyd A., Norgard B., Rasmussen H.H., Sorensen H.T., et al. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol 99 5 (2004 May) 884-888
12. Weersma R.K., Peters F.T., Oostenbrug L.E., van den Berg A.P., van Haastert M., Ploeg R.J., et al. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther 20 8 (2004 Oct 15) 843-850
13. Karch F.E., and Lasagna L. Adverse drug reactions. A critical review. JAMA 234 12 (1975 Dec 22) 1236-1241
14. Werth B., Kuhn M., Hartmann K., Reinhart W.H., et al. [Drug-induced pancreatitis: experience of the Swiss drug adverse effects center (SANZ) 1981-1993]. Schweiz Med Wochenschr 125 15 (1995 Apr 15) 731-734
15. Trivedi C.D., and Pitchumoni C.S. Drug-induced pancreatitis: an update. J Clin Gastroenterol 39 8 (2005 Sep) 709-716
16. Floyd A., Pedersen L., Nielsen G.L., Thorlacius-Ussing O., Sorensen H.T., et al. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. Am J Gastroenterol 98 6 (2003 Jun) 1305-1308
17. Norgaard M., Ratanajamit C., Jacobsen J., Skriver M.V., Pedersen L., Sorensen H.T., et al. Metronidazole and risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 21 4 (2005 Feb 15) 415-420
18. Norgaard M., Jacobsen J., Ratanajamit C., Jepsen P., McLaughlin J.K., Pedersen L., et al. Valproic acid and risk of acute pancreatitis: a population-based case-control study. Am J Ther 13 2 (2006 Mar-Apr) 113-117
19. Norgaard M., Jacobsen J., Gasse C., Pedersen L., Mortensen P.B., Sorensen H.T., et al. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study. J Clin Psychopharmacol 27 3 (2007 Jun) 259-262
20. Gasse C., Jacobsen J., Pedersen L., Mortensen P.B., Norgaard M., Sorensen H.T., et al. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study. Pharmacotherapy 28 1 (2008 Jan) 27-34
21. Floyd A., Pedersen L., Nielsen G.L., Thorlacius-Ussing O., Sorensen H.T., et al. Risk of acute pancreatitis in users of finasteride: a population-based case-control study. J Clin Gastroenterol 38 3 (2004 Mar) 276-278
22. Tetsche M.S., Jacobsen J., Norgaard M.S., Baron J.A., Sorensen H.T., et al. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol 102 2 (2007 Feb) 275-278
23. Sorensen H.T., Jacobsen J., Norgaard M., Pedersen L., Johnsen S.P., Baron J.A., et al. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis. Aliment Pharmacol Ther 24 1 (2006 Jul 1) 111-116
24. Eland I., Sundstrom A., Velo G.P., Andersen M., Sturkenboom M.C., Langman M.J., et al. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol 41 12 (2006 Dec) 1484-1490
25. Morinville V.D., et al. Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. Pancreas 35 4 (2007) 308-312
26. Smith C.J., Olsen C.H., Mocroft A., Viard J.P., Staszewski S., Panos G., et al. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study. Aids, AIDS (London, England) 22 1 (2008 Jan 2) 47-56
27. Singh V.P., et al. Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol 296 5 (2009) G1040-6